Skip to main content
. 2022 Mar 1;36(5-6):300–312. doi: 10.1101/gad.349232.121

Figure 6.

Figure 6.

Metabolic phenotypes of PPARγ1 KO and PPARγ2 KO mice under HFD treatment. (A,D) Body weight gain of PPARγ1 KO (A) and PPARγ2 KO (D) mice and their control littermates on HFD. n = 5–13 per group. (B,E) iWAT, eWAT, and BAT weights from PPARγ1 KO (B) and PPARγ2 KO (E) mice and their control littermates after 12 wk of HFD. n = 5–13 per group. (C,F) Intraperitoneal glucose tolerance test of PPARγ1 KO (C) and PPARγ2 KO (F) mice and their control littermates under 12-wk HFD treatment. n = 5–13 per group. Data are expressed as mean ± SEM. (*) P < 0.05, (**) P < 0.01, (ns) not significant; Student's t-test.